Europe

Cancer Core Europe consortium launches

Friday, September 26, 2014

Cancer Core Europe—a consortium to address the cancer care/research continuum challenge, has launched. Its members are Gustave Roussy Cancer Campus Grand Paris; Cambridge Cancer Center, based in the U.K.; Karolinska Institute, of Stockholm, Sweden; the Netherlands Cancer InstituteVall d’Hebron Institute of Oncology (VHIO), of Barcelona, Spain; and the German Cancer Research Center (DKFZ) and its National Center for Tumor Diseases (NCT).

[Read More]

Icon’s Cynthia Dukes voted one of the world’s Most Influential People in Vaccines

Thursday, September 18, 2014

Icon, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, has announced that Cynthia Dukes, vice president, global project management, vaccines, infectious disease, women’s health and primary care, has been voted one of the 50 Most Influential People in Vaccines following a global industry survey conducted by vaccine industry organization, VaccineNation. Cynthia was the only CRO representative included in the list.

[Read More]

Health advocate coalition says EMA advice for fee undermines independence of regulatory authorities

Monday, September 15, 2014

Health Action International Europe (HAI Europe), the International Society of Drug Bulletins (ISDB), the Medicines in Europe Forum (MiEF) and the Association Internationale de la Mutualité (AIM) have criticized the EMA for providing confidential “advice” to pharmaceutical companies on their development plans for new medicines in exchange for fees—a potentially harmful practice the EMA now is trying to extend to national health technology assessment (HTA) bodies in the E.U.

[Read More]